Credit Suisse’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $29.8M | Sell |
2,008,046
-806,270
| -29% | -$11.9M | 0.03% | 524 |
|
|
2023
Q4 | $22.9M | Sell |
2,814,316
-29,153
| -1% | -$237K | 0.02% | 622 |
|
|
2023
Q3 | $12.9M | Buy |
2,843,469
+49,345
| +2% | +$225K | 0.01% | 793 |
|
|
2023
Q2 | $19.7M | Buy |
2,794,124
+97,282
| +4% | +$685K | 0.02% | 669 |
|
|
2023
Q1 | $16.5M | Buy |
2,696,842
+31,262
| +1% | +$191K | 0.02% | 721 |
|
|
2022
Q4 | $17M | Buy |
2,665,580
+55,875
| +2% | +$357K | 0.02% | 716 |
|
|
2022
Q3 | $25M | Sell |
2,609,705
-28,597
| -1% | -$274K | 0.03% | 588 |
|
|
2022
Q2 | $29.1M | Buy |
2,638,302
+140,769
| +6% | +$1.55M | 0.03% | 559 |
|
|
2022
Q1 | $41.6M | Buy |
2,497,533
+60,717
| +2% | +$1.01M | 0.04% | 510 |
|
|
2021
Q4 | $46.5M | Buy |
2,436,816
+21,203
| +0.9% | +$405K | 0.02% | 498 |
|
|
2021
Q3 | $59.6M | Buy |
2,415,613
+3,410
| +0.1% | +$84.1K | 0.03% | 415 |
|
|
2021
Q2 | $62.8M | Buy |
2,412,203
+17,714
| +0.7% | +$461K | 0.03% | 425 |
|
|
2021
Q1 | $75.8M | Buy |
2,394,489
+2,368,369
| +9,067% | +$75M | 0.04% | 395 |
|
|
2020
Q4 | $1.21M | Sell |
26,120
-29,612
| -53% | -$1.37M | ﹤0.01% | 2448 |
|
|
2020
Q3 | $1.84M | Sell |
55,732
-22,494
| -29% | -$741K | ﹤0.01% | 1866 |
|
|
2020
Q2 | $2.15M | Buy |
78,226
+70,598
| +926% | +$1.94M | ﹤0.01% | 1819 |
|
|
2020
Q1 | $228K | Sell |
7,628
-1,417,880
| -99% | -$42.4M | ﹤0.01% | 2975 |
|
|
2019
Q4 | $39.5M | Sell |
1,425,508
-100,414
| -7% | -$2.78M | 0.03% | 506 |
|
|
2019
Q3 | $27.8M | Sell |
1,525,922
-44,384
| -3% | -$808K | 0.02% | 561 |
|
|
2019
Q2 | $38.5M | Sell |
1,570,306
-319,988
| -17% | -$7.85M | 0.03% | 434 |
|
|
2019
Q1 | $18M | Buy |
1,890,294
+421
| +0% | +$4K | 0.02% | 717 |
|
|
2018
Q4 | $16.7M | Buy |
1,889,873
+329,048
| +21% | +$2.91M | 0.02% | 719 |
|
|
2018
Q3 | $17.6M | Buy |
1,560,825
+529,511
| +51% | +$5.96M | 0.02% | 788 |
|
|
2018
Q2 | $13.2M | Sell |
1,031,314
-420,246
| -29% | -$5.38M | 0.01% | 888 |
|
|
2018
Q1 | $24.5M | Buy |
1,451,560
+356,132
| +33% | +$6.02M | 0.02% | 640 |
|
|
2017
Q4 | $8.76M | Buy |
1,095,428
+1,021,734
| +1,386% | +$8.17M | 0.01% | 1108 |
|
|
2017
Q3 | $571K | Buy |
73,694
+47,143
| +178% | +$365K | ﹤0.01% | 2998 |
|
|
2017
Q2 | $196K | Sell |
26,551
-9,052
| -25% | -$66.8K | ﹤0.01% | 3236 |
|
|
2017
Q1 | $265K | Buy |
35,603
+1,351
| +4% | +$10.1K | ﹤0.01% | 3188 |
|
|
2016
Q4 | $238K | Sell |
34,252
-10,078
| -23% | -$70K | ﹤0.01% | 3387 |
|
|
2016
Q3 | $366K | Sell |
44,330
-2,690
| -6% | -$22.2K | ﹤0.01% | 3243 |
|
|
2016
Q2 | $381K | Buy |
47,020
+4,833
| +11% | +$39.2K | ﹤0.01% | 3273 |
|
|
2016
Q1 | $215K | Sell |
42,187
-1,191
| -3% | -$6.07K | ﹤0.01% | 3357 |
|
|
2015
Q4 | $335K | Buy |
43,378
+20,986
| +94% | +$162K | ﹤0.01% | 3408 |
|
|
2015
Q3 | $129K | Sell |
22,392
-1,722
| -7% | -$9.92K | ﹤0.01% | 3839 |
|
|
2015
Q2 | $221K | Sell |
24,114
-28,824
| -54% | -$264K | ﹤0.01% | 3879 |
|
|
2015
Q1 | $641K | Buy |
+52,938
| New | +$641K | ﹤0.01% | 3102 |
|